Optimization of lipid-indinavir complexes for localization in lymphoid tissues of HIV-infected macaques

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 2, 2006, Pages 155-161

  Kinman, Loren ^a   Bui, Tot ^a   Larsen, Kay ^a   Tsai, Che Chung ^a   Anderson, David ^a   Morton, William R ^a   Hu, Shiu Lok ^a   Ho, Rodney J Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antiretroviral therapy; HIV 1; HIV 2; Lipid associated drug; Protease macaque model

Indexed keywords

AMINE; CHOLINE DERIVATIVE; DISTEAROYLPHOSPHATIDYLCHOLINE; INDINAVIR; LIPID; METHYL POLYETHYLENE GLYCOL DISTEAROYLPHOSPHATIDYLETHANOLAMINE; NANOPARTICLE; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXPOSURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE; LYMPHOID TISSUE; MACACA; NONHUMAN; PH; PRIORITY JOURNAL;

ANIMALS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CELL LINE; DISEASE MODELS, ANIMAL; DRUG CARRIERS; HIV INFECTIONS; HIV-2; HYDROGEN-ION CONCENTRATION; INDINAVIR; INJECTIONS, SUBCUTANEOUS; LIPIDS; LYMPH NODES; LYMPHOID TISSUE; MACACA NEMESTRINA; NANOSTRUCTURES; PHOSPHATIDYLCHOLINES; RNA, VIRAL; TISSUE DISTRIBUTION;

EID: 33745096804     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000214822.33905.87     Document Type: Article

References (14)

1. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337:725-733.
2. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
3. Vittinghoff E, Scheer S, O'Malley P, et al. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis. 1999;179:717-720.
4. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science. 1997;276:960-964.
5. Hockett RD, Kilby JM, Derdeyn CA, et al. Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med. 1999;189:1545-1554.
6. Brodie SJ. Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease. J Leukoc Biol. 2000;68:351-359.
7. Brodie SJ, Patterson BK, Lewinsohn DA, et al. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. J Clin Invest. 2000;105:1407-1417.
8. Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278:1291-1295.
9. Wong JK, Gunthard HF, Havlir DV, et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologie correlates of treatment failure. Proc Natl Acad Sci U S A. 1997;94:12574-12579.
10. Ruiz L, van Lunzen J, Arno A, et al. Protease inhibitor - containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue. AIDS. 1999;13:F1-8.
11. Kinman L, Brodie SJ, Tsai CC, et al. Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287 - infected macaques. J Acquir Immune Defic Syndr. 2003;34:387-397.
12. Solas C, Lafeuillade A, Halfon P, et al. Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2003;47:238-243.
13. Ho RJ, Agy MB, Morton WR, et al. Development of a chronically catheterized maternal-fetal macaque model to study in utero mother-to-fetus HIV transmission: a preliminary report. J Med Primatol. 1996;25:218-224.
14. Oussoren C, Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev. 2001;50:143-156.